<DOC>
	<DOCNO>NCT02071134</DOCNO>
	<brief_summary>The purpose registry compile characteristic world-wide outcome use Boston Scientific 's commercially available Vercise DBS system treatment Parkinson 's disease .</brief_summary>
	<brief_title>Registry Deep Brain Stimulation With VERCISEâ„¢ System : Vercise DBS Registry</brief_title>
	<detailed_description>The purpose registry compile characteristic world-wide outcome use Boston Scientific 's commercially available Vercise DBS system treatment Parkinson 's disease . Subjects ' improvement disease symptom overall Quality life assess study follow DBS compare baseline .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Meets criterion establish locally applicable Vercise System Direction Use At least 18 year old Meets contraindication Vercise System locally applicable Directions Use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Deep brain stimulation</keyword>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Vercise</keyword>
</DOC>